Moussa, M. et al. 2022. The safety and effectiveness of mirabegron in Parkinson’s disease patients with overactive bladder: a randomized controlled trial. Scandinavian Journal of Urology. 56, 1 (Jan. 2022), 66–72. DOI:https://doi.org/10.1080/21681805.2021.1990994.